CollPlant Biotechnologies (CLGN) News Today $3.74 +0.06 (+1.63%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CollPlant Biotechnologies (NASDAQ:CLGN) Stock Quotes, Forecast and News SummaryOctober 13, 2024 | benzinga.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest UpdateCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 9,900 shares, a growth of 5.3% from the August 31st total of 9,400 shares. Based on an average trading volume of 12,200 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the shares of the stock are sold short.October 1, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 9,400 shares, an increase of 11.9% from the August 15th total of 8,400 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 12,800 shares, the short-interest ratio is currently 0.7 days.September 16, 2024 | marketbeat.comHC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN)CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - HC Wainwright lifted their Q3 2024 earnings per share estimates for shares of CollPlant Biotechnologies in a report released on Wednesday, August 21st. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.37)August 26, 2024 | marketbeat.comHC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - Stock analysts at HC Wainwright cut their FY2027 earnings per share estimates for CollPlant Biotechnologies in a research report issued to clients and investors on Wednesday, August 21st. HC Wainwright analyst S. Ramakanth now anticipatAugust 23, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | seekingalpha.comCracking The Code: Understanding Analyst Reviews For CollPlant BiotechnologiesAugust 21, 2024 | benzinga.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | msn.comCollPlant Biotechnologies Posts Loss In Q2 - Quick FactsAugust 20, 2024 | markets.businessinsider.comEven after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three yearsAugust 20, 2024 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEAugust 20, 2024 | prnewswire.comCollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast ImplantsAugust 19, 2024 | prnewswire.comCollPlant Biotechnologies (NASDAQ:CLGN) Upgraded at EF Hutton Acquisition Co. IEF Hutton Acquisition Co. I raised CollPlant Biotechnologies to a "strong-buy" rating in a report on Monday.August 6, 2024 | marketbeat.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATIONAugust 6, 2024 | prnewswire.comCollPlant Biotechnologies Unveils Inaugural ESG and Sustainability ReportJuly 29, 2024 | prnewswire.comCollplant Biotechnologies Ltd (CLGN)July 28, 2024 | investing.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Increase in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, an increase of 533.3% from the June 30th total of 600 shares. Based on an average trading volume of 8,000 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the company's stock are short sold.July 25, 2024 | marketbeat.comShort Interest in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Drops By 64.7%CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 600 shares, a decrease of 64.7% from the June 15th total of 1,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 7,600 shares, the days-to-cover ratio is currently 0.1 days.July 11, 2024 | marketbeat.comShort Interest in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Declines By 26.1%CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 1,700 shares, a drop of 26.1% from the May 31st total of 2,300 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 7,200 shares, the short-interest ratio is currently 0.2 days.July 1, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Down 66.2% in MayCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 2,300 shares, a decline of 66.2% from the May 15th total of 6,800 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 6,200 shares, the short-interest ratio is currently 0.4 days.June 12, 2024 | marketbeat.comCollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical DataJune 6, 2024 | prnewswire.comCLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024May 29, 2024 | investorplace.comCollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate UpdateMay 29, 2024 | prnewswire.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONMay 16, 2024 | prnewswire.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Drop in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,800 shares, a decline of 34.8% from the April 15th total of 8,900 shares. Based on an average daily trading volume, of 6,900 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the company's shares are short sold.May 12, 2024 | marketbeat.comCollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its BusinessApril 23, 2024 | finance.yahoo.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 33.3% in MarchCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 10,800 shares, an increase of 33.3% from the March 15th total of 8,100 shares. Based on an average daily trading volume, of 8,200 shares, the short-interest ratio is currently 1.3 days. Approximately 0.1% of the shares of the company are short sold.April 13, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call TranscriptApril 8, 2024 | msn.comCollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call TranscriptApril 6, 2024 | seekingalpha.comCollPlant Biotechnologies (NASDAQ:CLGN) Rating Reiterated by HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $11.00 price objective on shares of CollPlant Biotechnologies in a report on Friday.April 5, 2024 | marketbeat.comCollPlant Biotechnologies FY23 Net Loss NarrowsApril 4, 2024 | markets.businessinsider.comCLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023April 4, 2024 | msn.comUS Index Futures Rise, Oil Dips SlightlyApril 4, 2024 | msn.comCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEApril 4, 2024 | prnewswire.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Decrease in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 8,100 shares, a drop of 13.8% from the February 29th total of 9,400 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is presently 0.7 days. Approximately 0.1% of the company's stock are short sold.March 30, 2024 | marketbeat.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONMarch 26, 2024 | finance.yahoo.comCollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on WednesdayCollPlant Biotechnologies (NASDAQ:CLGN) will be releasing earnings on Wednesday, March 27, Yahoo Finance reports.March 26, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 20.5% in FebruaryCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 9,400 shares, an increase of 20.5% from the February 14th total of 7,800 shares. Approximately 0.1% of the company's shares are sold short. Based on an average daily trading volume, of 14,000 shares, the days-to-cover ratio is presently 0.7 days.March 15, 2024 | marketbeat.comCollPlant Issues Letter to ShareholdersFebruary 15, 2024 | finance.yahoo.comCollPlant Issues Letter to ShareholdersFebruary 15, 2024 | prnewswire.comCOLLPLANT BIOTECH. IS-,01 (CPT.MU)February 13, 2024 | au.finance.yahoo.comCollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, CaliforniaJanuary 8, 2024 | finance.yahoo.comCollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast ImplantsJanuary 2, 2024 | finance.yahoo.comCollPlant Biotechnologies Stock (NASDAQ:CLGN), Analyst Ratings, Price Targets, PredictionsDecember 2, 2023 | benzinga.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call TranscriptDecember 1, 2023 | finance.yahoo.comRecap: CollPlant Biotechnologies Q3 EarningsNovember 29, 2023 | benzinga.comCollPlant Biotechnologies Non-GAAP EPS of -$0.35November 29, 2023 | msn.comCollPlant Biotechnologies Announces Third Quarter Financial Results for 2023November 29, 2023 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONNovember 9, 2023 | finance.yahoo.comWill CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely?November 3, 2023 | finance.yahoo.com Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here CLGN Media Mentions By Week CLGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLGN News Sentiment▼0.000.43▲Average Medical News Sentiment CLGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLGN Articles This Week▼01▲CLGN Articles Average Week Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BrainsWay News Today Fractyl Health News Today Alpha Tau Medical News Today Lakeland Industries News Today KORU Medical Systems News Today TriSalus Life Sciences News Today Sensus Healthcare News Today Edap Tms News Today Pro-Dex News Today FONAR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLGN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
